Henry Schein, Inc.

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-10 pm EDT			5-day change	1st Jan Change
73.31 ^USD	-0.18%		+8.16%	-3.17%

May. 08	UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating	MT
May. 08	Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating	MT

HENRY SCHEIN INC : Change in Directors or Principal Officers, Regulation FD Disclosure (form 8-K)

April 06, 2020 at 07:25 am EDT

-weight:bold;text-align:center;font-size:12pt;margin-bottom:0pt;margin-top:0pt">of

the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 3, 2020

Henry Schein, Inc.

(Exact name of registrant as specified in its charter)

Delaware

0-27078

11-3136595

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

135 Duryea Road, Melville, New York

11747

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (631) 843-5500

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Latest news about Henry Schein, Inc.

UBS Adjusts Price Target on Henry Schein to $80 From $82, Maintains Neutral Rating	May. 08	MT
Barrington Ups Price Target on Henry Schein to $92 From $90, Maintains Outperform Rating	May. 08	MT
Goldman Sachs Adjusts Price Target on Henry Schein to $74 From $76	May. 08	MT
Baird Adjusts Price Target on Henry Schein to $81 From $83, Maintains Neutral Rating	May. 08	MT
Transcript : Henry Schein, Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
Stocks Mostly Up Pre-Bell Ahead of Latest Earnings Releases; Asia, Europe Rise	May. 07	MT
Henry Schein's Q1 Non-GAAP Earnings Decline, Revenue Rises	May. 07	MT
Earnings Flash (HSIC) HENRY SCHEIN Reports Q1 Revenue $3.17B, vs. Street Est of $3.20B	May. 07	MT
Earnings Flash (HSIC) HENRY SCHEIN Reports Q1 EPS $1.10, vs. Street Est of $1.01	May. 07	MT
Henry Schein, Inc. Reports Earnings Results for the First Quarter Ended March 30, 2024	May. 07	CI
Henry Schein, Inc. Revises Earnings Guidance for the Year 2024	May. 07	CI
Leerink Partners Adjusts Henry Schein's Price Target to $77 From $82, Keeps Market Perform Rating	Apr. 12	MT
Constellation Brands, Inc: Cash machine	Apr. 12
Henry Schein, Inc. Announces Appointment of Members to the Company?S Executive Management Committee	Apr. 10	CI
Henry Schein Closes Acquisition of Majority Stake in TriMed	Apr. 04	MT
Henry Schein, Inc. completed the acquisition of an unknown majority interest in TriMed, Inc.	Apr. 03	CI
Viome Is Partnering with Henry Schein, Inc. to Provide Better Access to Oral Health Pro with Cancerdetect	Apr. 02	CI
Henry Schein Insider Sold Shares Worth $477,620, According to a Recent SEC Filing	Mar. 21	MT
JPMorgan Adjusts Henry Schein's Price Target to $88 From $82, Reiterates Overweight Rating	Mar. 06	MT
Jefferies Adjusts Henry Schein's Price Target to $81 From $74, Maintains Hold Rating	Mar. 06	MT
Barrington Boosts Price Target on Henry Schein to $90 From $82, Keeps Outperform Rating	Feb. 28	MT
Transcript : Henry Schein, Inc., Q4 2023 Earnings Call, Feb 27, 2024	Feb. 27
Henry Schein forecasts 2024 profit below estimates as cyber attack impact weighs	Feb. 27	RE
Stocks Rise Pre-Bell as Investors Digest Latest Corporate Earnings; Asia Up, Europe Mixed	Feb. 27	MT
Henry Schein Q4 Adjusted Earnings, Net Sales Fall; Sets 2024 Guidance	Feb. 27	MT

Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows: - distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.); - other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services. The United States account for 69.9% of net sales.Henry Schein, Inc. specializes in the distribution of care products and services intended for health professionals (doctors, surgeons, dentists, veterinary laboratories and clinics). Net sales break down by activity as follows: - distribution of health care products and equipment (93.5%): dental products and equipment (65.4% of net sales; consumable products, laboratory equipment, print materials, implants, anesthetics, etc.) and medical equipment (34.6%; medicines, vaccines, vitamins, surgical material, diagnostic tests, etc.); - other (6.5%): sale and integration of management software, financial, training, maintenance and equipment repair services. The United States account for 69.9% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-14 - BofA Securities Health Care Conference

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Henry Schein, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

73.31 USD

Average target price

79.75 USD

Spread / Average Target

+8.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

	1st Jan change	Capi.
HENRY SCHEIN, INC.	-3.17%	9.39B
SHIP HEALTHCARE HOLDINGS, INC.	-0.44%	1.45B
OWENS & MINOR, INC.	-3.32%	1.43B
AS ONE CORPORATION	-5.79%	1.21B
GKHT MEDICAL TECHNOLOGY CO., LTD.	-14.59%	899M
TOKAI CORP.	+1.72%	480M
EXCELSIOR MEDICAL CO., LTD.	+3.85%	440M
GAUSH MEDITECH LTD	-48.41%	369M
COWEALTH MEDICAL CHINA CO.,LTD.	-19.75%	356M
WIN-PARTNERS CO., LTD.	-2.93%	213M

Medical Equipment Wholesale

Henry Schein, Inc.

Equities

HSIC

US8064071025

Medical Equipment, Supplies & Distribution

HENRY SCHEIN INC : Change in Directors or Principal Officers, Regulation FD Disclosure (form 8-K)

Latest news about Henry Schein, Inc.

Chart Henry Schein, Inc.

Company Profile

Income Statement Evolution

Ratings for Henry Schein, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Equipment Wholesale